Valuation: Certara, Inc.

Market Cap 1.33B 1.14B 1.06B 976M 1.83B 127B 1.87B 12.62B 4.92B 63.86B 5B 4.89B 211B P/E 2026 *
-42.3x
P/E 2027 * 932x
Enterprise Value 1.39B 1.19B 1.11B 1.02B 1.91B 133B 1.95B 13.15B 5.13B 66.53B 5.21B 5.1B 220B EV / Sales 2026 *
3.65x
EV / Sales 2027 * 3.36x
Free-Float
67.08%
Yield 2026 *
-
Yield 2027 * -
1 day+4.43%
1 week+7.12%
Current month+7.78%
1 month+25.79%
3 months+86.94%
6 months+35.14%
Current year-0.91%
1 week 7.86
Extreme 7.865
8.88
1 month 6.33
Extreme 6.332
8.88
Current year 4.45
Extreme 4.45
10.2
1 year 4.45
Extreme 4.45
13.88
3 years 4.45
Extreme 4.45
19.87
5 years 4.45
Extreme 4.45
45.48
10 years 4.45
Extreme 4.45
45.48
Manager TitleAgeSince
Chief Executive Officer 53 2025-12-31
Director of Finance/CFO 53 2026-07-14
Chief Tech/Sci/R&D Officer - 2025-07-30
Director TitleAgeSince
Chairman 72 2021-11-30
Director/Board Member 68 2012-12-31
Director/Board Member 59 2017-07-31
Date Insider Type Main position Quantity % Market Cap.
7/15/26 Other

Chief Financial Officer

191,850 0.1233%
5/11/26 Issuer sale

Executive/Senior Manager

-599,657 0.3911%
4/1/26 Fiscal year

Head of Human Resources

22,590 0.0142%
Change 5-day change 1-year change 3-year change Capi.($)
+4.43%+7.12%-18.33%-45.57% 1.33B
-0.47%-3.17%-4.86%+52.03% 3,573B
-0.70%-2.82%+11.51%+1,108.06% 418B
-0.44%-3.14%-9.22%+42.19% 86.36B
-0.42%-7.81%+81.03%+148.37% 83.5B
-0.83%-3.36%-33.80%-6.60% 76.19B
-1.56%-4.93%-34.41%+203.10% 71.81B
+1.31%-0.73%+5.02%+74.71% 44.9B
+0.39%+5.38%+5.02%-6.11% 44.28B
-0.04%+6.26%-18.54%-37.83% 34.37B
Average +0.30%-0.59%-1.66%+153.23% 443.36B
Weighted average by Cap. +0.48%-3.05%-2.67%+153.59%

Financials

2026 *2027 *
Net sales 380M 325M 304M 279M 524M 36.37B 534M 3.6B 1.4B 18.23B 1.43B 1.4B 60.34B 390M 334M 311M 286M 537M 37.27B 547M 3.69B 1.44B 18.68B 1.46B 1.43B 61.84B
Net income -28.37M -24.29M -22.66M -20.8M -39.08M -2.71B -39.85M -269M -105M -1.36B -107M -104M -4.5B 1.74M 1.49M 1.39M 1.27M 2.39M 166M 2.44M 16.47M 6.42M 83.32M 6.52M 6.38M 276M
Net Debt 55.8M 47.78M 44.58M 40.91M 76.86M 5.34B 78.38M 529M 206M 2.68B 210M 205M 8.86B -23.11M -19.79M -18.46M -16.94M -31.84M -2.21B -32.46M -219M -85.39M -1.11B -86.79M -84.9M -3.67B
Logo Certara, Inc.
Certara, Inc. is a provider of biosimulation science, technology, and consulting services for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical and biotech industry. The Company's proprietary biosimulation platforms are built on biology, chemistry, and pharmacology principles with proprietary mathematical algorithms that model how medicines and diseases behave in the body. It has developed scientifically-based solutions for the collection, standardization, validation, storage, and analysis of the preclinical, clinical and evidence data needed for MIDD. These data solutions are used internally and industry-wide by life sciences companies. The Company applies AI capabilities within established modeling environments and under the supervision of experienced scientists and regulatory experts. Its modeling platforms and curated datasets position it to incorporate emerging AI techniques in a controlled and scientifically rigorous manner.
Employees
1,546
Date Price Change Volume
26-08-20 US$8.730 +4.43% 2,704,970
26-08-19 US$8.360 +4.37% 2,026,419
26-08-18 US$8.010 +0.12% 1,940,532
26-08-17 US$8.000 0.00% 4,654,924
26-08-14 US$8.000 -1.84% 1,429,348
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
8.730USD
Average target price
8.185USD
Spread / Average Target
-6.24%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CERT Stock